139 related articles for article (PubMed ID: 24083341)
1. Should hydroxyethyl starch solutions be totally banned?
Vincent JL; Kellum JA; Shaw A; Mythen MG
Crit Care; 2013 Oct; 17(5):193. PubMed ID: 24083341
[TBL] [Abstract][Full Text] [Related]
2. Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
Bellomo R; Bion J; Finfer S; Myburgh J; Perner A; Reinhart K;
Br J Anaesth; 2014 Mar; 112(3):595-600. PubMed ID: 24535531
[No Abstract] [Full Text] [Related]
3. Why hydroxyethyl starch solutions should NOT be banned from the operating room.
De Hert S; De Baerdemaeker L
Anaesthesiol Intensive Ther; 2014; 46(5):336-41. PubMed ID: 25432553
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyethyl-starch use and PBM: a necessary update to the Italian national guidelines.
Biancofiore G; Vaglio S; Liumbruno GM
Blood Transfus; 2016 May; 14(2):195-6. PubMed ID: 27177414
[No Abstract] [Full Text] [Related]
5. Counter statement to open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation.
Coriat P; Guidet B; de Hert S; Kochs E; Kozek S; Van Aken H;
Br J Anaesth; 2014 Jul; 113(1):194-5. PubMed ID: 24942721
[No Abstract] [Full Text] [Related]
6. Is fluid resuscitation with high-volume hydroxyethyl starch safe for the kidney in trauma patients?
Xue FS; Liu GP; Li RP; Sun C
Injury; 2015 Aug; 46(8):1698-9. PubMed ID: 25823537
[No Abstract] [Full Text] [Related]
7. Nephrotoxicity of hydroxyethyl starch solution.
Brunkhorst FM; Oppert M
Br J Anaesth; 2008 Jun; 100(6):856; author reply 856-7. PubMed ID: 18483113
[No Abstract] [Full Text] [Related]
8. Is the literature inconclusive about the harm from HES? Yes.
Ertmer C; Annane D; Van Der Linden P
Intensive Care Med; 2017 Oct; 43(10):1520-1522. PubMed ID: 27007102
[No Abstract] [Full Text] [Related]
9. [Hydroxyethyl starch for volume replacement therapy - a swan song?].
Ittner KP
Dtsch Med Wochenschr; 2013 Nov; 138(48):2450. PubMed ID: 24254341
[No Abstract] [Full Text] [Related]
10. Starch solutions in Australia: the empire strikes back.
Bellomo R
Crit Care Resusc; 2013 Dec; 15(4):253-4. PubMed ID: 24289503
[No Abstract] [Full Text] [Related]
11. Tetrastarch solutions: are they definitely dead?
Moral V; Aldecoa C; Asuero MS
Br J Anaesth; 2013 Sep; 111(3):324-7. PubMed ID: 23946355
[No Abstract] [Full Text] [Related]
12. Is the literature inconclusive about the harm of HES? We are not sure.
Schetz M; Shaw AD; Vincent JL
Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
[No Abstract] [Full Text] [Related]
13. Is the literature inconclusive about the harm from HES? No.
Wiedermann CJ; Bellomo R; Perner A
Intensive Care Med; 2017 Oct; 43(10):1523-1525. PubMed ID: 27007101
[No Abstract] [Full Text] [Related]
14. [Not Available].
Hahn R
Lakartidningen; 2018 May; 115():. PubMed ID: 29738050
[No Abstract] [Full Text] [Related]
15. Trauma experts urge cautious use of i.v. fluids.
Traynor K
Am J Health Syst Pharm; 2012 Nov; 69(21):1846, 1848. PubMed ID: 23111663
[No Abstract] [Full Text] [Related]
16. Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
Patel A; Waheed U; Brett SJ
Intensive Care Med; 2013 Aug; 39(8):1507-8. PubMed ID: 23736140
[No Abstract] [Full Text] [Related]
17. Hydroxyethyl starch solutions and patient harm.
Roberts I; Shakur H; Bellomo R; Bion J; Finfer S; Hunt B; Myburgh J; Perner A; Reinhart K
Lancet; 2018 Feb; 391(10122):736. PubMed ID: 29449012
[No Abstract] [Full Text] [Related]
18. But is it safe? Hydroxyethyl starch in perioperative care.
Greenberg S; Tung A
Anesth Analg; 2015 Mar; 120(3):519-521. PubMed ID: 25695570
[No Abstract] [Full Text] [Related]
19. Faulty risk-of-bias assessment in a meta-analysis of hydroxyethyl starch for nonseptic ICU patients.
Bayer O; Reinhart K
Crit Care; 2015 Oct; 19():357. PubMed ID: 26446864
[No Abstract] [Full Text] [Related]
20. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
